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ABSTRACT
Genetic recombination in single-strand, positive-
sense RNA viruses is a poorly understand mecha-
nism responsible for generating extensive genetic
change and novel phenotypes. By moving a crit-
ical cis-acting replication element (CRE) from the
polyprotein coding region to the 3′ non-coding region
we have further developed a cell-based assay (the
3′CRE-REP assay) to yield recombinants throughout
the non-structural coding region of poliovirus from
dually transfected cells. We have additionally devel-
oped a defined biochemical assay in which the only
protein present is the poliovirus RNA dependent RNA
polymerase (RdRp), which recapitulates the strand
transfer events of the recombination process. We
have used both assays to investigate the role of the
polymerase fidelity and nucleotide turnover rates in
recombination. Our results, of both poliovirus inter-
typic and intratypic recombination in the CRE-REP
assay and using a range of polymerase variants in
the biochemical assay, demonstrate that RdRp fi-
delity is a fundamental determinant of recombination
frequency. High fidelity polymerases exhibit reduced
recombination and low fidelity polymerases exhibit
increased recombination in both assays. These stud-
ies provide the basis for the analysis of poliovirus re-
combination throughout the non-structural region of
the virus genome and provide a defined biochemical
assay to further dissect this important evolutionary
process.
INTRODUCTION
Recombination in single-stranded, positive-sense RNA
viruses is a relatively poorly understood driver of extensive
genetic change. This group of viruses, typified by poliovirus,
exist as viral quasispecies as a consequence of misincorpo-
rations by their error-prone RNA dependent RNA poly-
merases (RdRp) during genome replication coupled with
strand transfer events that create hybrids (recombinants)
between two viruses replicating in the same cell. As well as
being a driver of genetic variation, recombination may have
evolved to ‘rescue’ genomes fromdeleteriousmutations that
accumulate during error-prone replication (1) though this
may only be important for small population sizes such as
might occur during inter-host transmission (2).
Poliovirus, the prototype picornavirus and aetiological
agent of paralytic poliomyelitis, provides a tractable experi-
mental system to study recombination. The 7.5 kb genome
encodes a single polyprotein, flanked by non-coding regions
(NCR), that is co- and post-translationally processed to
generate the structural proteins (the P1 proteins; VP4, VP2,
VP3 and VP1) which assemble to form the icosahedral cap-
sid and the non-structural proteins (the P2 and P3 proteins;
2Apro, 2B, 2C, 3A, 3BVPg, 3Cpro and 3Dpol) that subvert
the cellular environment and replicate the virus genome.
The genome can essentially be considered modular, con-
sisting of structural (P1) and replication (P2 and P3) com-
ponents, together with the flanking translation and repli-
cation determinants occupying the 5′ and 3′ NCRs (3,4).
This modularity is emphasized in in vitro studies in which
viable recombinants have been engineered or selected (5,6).
More compellingly, studies of paralysis induced by vaccine
derived recombinant polioviruses (VDRP)––in which the
live attenuated Sabin vaccine strain has recombined with
a co-circulating species C enterovirus––have demonstrated
the importance of recombination in vivo (7). In related en-
teroviruses, recombinant forms––defined by serotype ac-
cording to their capsid proteins––have been shown to
emerge, prevail and then disappear in temporal epidemio-
logical surveys of globally-distributed serotypes (8–10). In
these examples the recombinants are pathogenic (generally
associated with poliomyelitis, a range of acute flaccid paral-
yses or viral encephalitis) and demonstrate maintenance
and transmission of the capsid in the population by a range
of non-structural ‘modules’ from genetically-related but di-
vergent viruses. An improved mechanistic understanding of
recombination is required, both to comprehend the process
as a driver of evolutionary change and to develop strate-
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gies to prevent or mitigate the consequences of recombina-
tion, for example by the design of non-recombinogenic live-
attenuated vaccines.
We have recently described an in vitro assay (designated
the CRE-REP assay) that enabled the identification of early
recombination products (11). Briefly, the assay involves two
poliovirus genomes each containing a different deleterious
(and non-reverting) modification that prevents the produc-
tion of viable progeny. One genome, a sub-genomic repli-
con (12), was replication competent but did not encode
capsid proteins. The other contained a well-understood
mutation (designated SL3) in a critical cis-acting replica-
tion element (CRE), a defined stemloop structure essential
for positive-strand replication (13,14). Co-transfection of
murine cells––permissive for infection, but not-susceptible
due to the absence of the poliovirus receptor ––resulted
in the recovery of viable progeny following a recombina-
tion strand transfer event between the non-structural pro-
tein (P2 and P3) modules of the sub-genomic replicon (the
polymerase donor) and the structural (P1) module of the
CRE-defective SL3 genome. By using genomes of different
poliovirus serotypes with divergent sequences it was possi-
ble to unambiguously identify the recombination junction.
To our surprise, the majority of initial viable recombinants
were ‘imprecise’ and contained an in-frame partial genome
duplication. Subsequent serial passage resulted in the incre-
mental loss of the genome duplication, leaving a range of
‘precise’ junctions with no additional sequences (11). These
observations strongly suggest that recombination may be
biphasic, involving the formation of an initial imprecise
product that, through a process we termed resolution, yields
the genome-length recombinants that are typically isolated
in vivo. Further studies demonstrated that modifying the
polymerase fidelity significantly influenced the yield of re-
combinants, an observation supported by a recent study in
alphaviruses (15). This indicated both a fundamental role
for the polymerase in the process of recombination and that
the process was replicative and therefore different from pre-
viously described non-replicative recombination (16,17).
Although the CRE-REP assay enables the role of the
polymerase in recombination to be analysed it does not
demonstrate that the polymerase is sufficient for strand ex-
change. Furthermore, although modification of the poly-
merase fidelity influences recombination yield in the CRE-
REP assay, this does not exclude the possibility that this is
an indirect consequence of the polymerase interacting with
cellular components of the replication machinery. Recom-
bination occurs within membrane-bound replication com-
plexes (RCs), as shown by elegant imaging studies and the
demonstration that nocodazole––a drug that prevents RC
coalescence––inhibits the process (11,18). Since the compo-
nents of the RC are not fully understood we reasoned that
a defined in vitro recombination assay would enable the role
of viral, and possibly cellular, components to be more read-
ily delineated.Using such an assaywe demonstrate here that
the viral polymerase alone is sufficient for the strand trans-
fer reaction. In addition, by analysis of variants of the poly-
merase with well-characterised changes to the enzymes’ fi-
delity or nucleotide turnover, we demonstrate both that this
biochemically defined in vitro assay recapitulates aspects of
the CRE-REP assay and that the fidelity of the viral poly-
merase is a key determinant of the recombination process.
In support of this conclusion we demonstrate that the ma-
jority of in vitro-generated transfer products contain ad-
ditional nucleotides or mutations at or near the recombi-
nation junction. By modifying components of the in vitro
assay we show that the strand transfer event is sequence-
dependent. Finally, we modified the CRE-REP assay and
demonstrate that recombinant yield is influenced by the
distance between the deleterious mutations in the parental
genomes and can partially compensate for polymeraseswith
reduced nucleotide turnover. These studies will enable the
analysis of recombination events throughout the region en-
coding the non-structural proteins of poliovirus, and––by
extrapolation––to related enteroviruses and other positive
sense RNA viruses. This study provides the basis for the de-
tailed kinetic and mechanistic analysis of the initial strand-
transfer and subsequent resolution events critical for the
formation of both viable and competitively fit recombinant
viruses.
MATERIALS AND METHODS
Viruses and cell culture
Adherent monolayers of HeLa and L929 fibroblasts were
grown in Dulbecco’s Modified Eagle Medium (DMEM)
or Glasgow Minimum Essential Medium (GMEM supple-
mented with G418 antibiotic). Media was supplemented
with 100 U/ml penicillin, 100 g/ml streptomycin, 2 mM
L-glutamine and 10% heat inactivated (HI)-FBS. All cells
were passaged in the presence of trypsin–EDTA. Where
stated, guanidine hydrochloride (Sigma) was added to
growth media at 4 mM. Poliovirus type 1 (Mahoney) and
type 3 (Leon)were recovered following transfection ofRNA
generated in vitro (see below) from full-length cDNA. Virus
was quantified by plaque assay or TCID50 as appropriate
and as described previously (19). Virus growth analysis was
determined by synchronous infection of HeLa cells at a
multiplicity of infection (moi) of 10 pfu/cell, washing with
PBS to remove unadsorbed virus and incubation in fresh
media at 37◦C in an atmosphere containing 5% CO2. Su-
pernatant virus was quantified at various time points post
infection by plaque assay. Virus competition assays were
conducted by co-infection (at the specified ratios) of HeLa
cells with a final moi of 10 pfu/cell. When serially passag-
ing virus, harvested supernatant was diluted 1:4 with fresh
media.
Plasmids, in vitro transcription, cell transfection and recom-
binant virus characterisation
pRLucWT and pT7Rep3-L are, respectively, cDNAs in
pBR-derived plasmids encoding poliovirus type 1Mahoney
and type 3 Leon sub-genomic replicons with a luciferase
reporter gene inserted in-frame in place of the P1 cap-
sid coding region (13,20). pRLucWTG64S contains a Gly
to Ser substitution at residue 64 of the viral polymerase.
Derivatives of these replicons bearing substitution of lysine
359 with arginine (pRLucWTK359R and pT7Rep3-LK359R)
were constructed using standard molecular protocols and
verified by sequencing. pT7/SL3 has been described pre-
viously (13) and consists of a full-length poliovirus type
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3 (Leon) cDNA bearing 8 synonymous substitutions in
the cis-acting replication element (CRE) in the 2C-coding
region. pT7/SL3K359R was constructed by exchange of a
relevant restriction fragment from pT7Rep3-LK359R into
pT7/FLC, a plasmid carrying a full length cDNA for po-
liovirus type 3 Leon. A derivative of pRLucWT deleted for
the CRE in the native location (pRLucWTCRE) was gen-
erated by site directed mutagenesis introducing the same 8
substitutions defined in the SL3 mutant of poliovirus previ-
ously described (13). A synthetic CRE was introduced into
the region encoding the 3′ NCR of pRLucWTCRE by
first introducing a Bss HII site immediately following the
site of polyprotein termination and then adding comple-
mentary oligonucleotides for the Synth2 version of theCRE
(21) so creating pRLucWTCRE 3′CRE. Similar methods
were used to introduce a 3′CRE into a full length poliovirus
type 3 genome to create pFLCCRE 3′CRE.
Plasmids encoding type 1 and type 3 poliovirus genomes
(full length or sub-genomic) were linearized with Sal I and
Apa I respectively, transcribed in vitro using T7 RNA Poly-
merase (Fermentas), treated with 2 U DNAse Turbo (Am-
bion) to remove residual DNA template and the RNA tran-
scripts purified using RNeasy Mini Kit (Qiagen) before
spectrophotometric quantification. Unless otherwise spec-
ified 1g of RNA was transfected into near-confluent T25
flasks using Lipofectamine 2000 (Invitrogen).
Recovered recombinant viruses were isolated by limit
dilution and sequenced following RT-PCR amplification
across the recombination junction as described previously
(11). Viral RNA was extracted from clarified culture su-
pernatant using a Qiagen RNAeasy Mini kit, reverse tran-
scribed using Superscript II reverse transcriptase (Invit-
rogen) and an oligo-dT primer at 46◦C for 50 min with
the reaction terminated by incubation for 15 min at 70◦C.
PCR amplification of recombination junctions used tem-
plate cDNA and appropriate oligonucleotides as listed in
Supplementary Table T1 with KOD XL DNA polymerase
(Novagen) used according to the manufacturer’s protocol.
Growth competition studies between parental type 3 po-
liovirus andFLCCRE 3′CREwere conducted by coinfec-
tion at a final moi of 10pfu/cell using 1:1, 10:1 and 1:10 ra-
tios of input, with recovered virus being RT-PCR amplified
across the region encoding the 2C-CRE followed by Swa I
digestion of the PCR product and agarose gel electrophore-
sis.
Luciferase assays
Supernatant was removed from transfected cell monolayers,
cells were briefly washed with PBS and lysed using 200 l
1×Glo Lysis Buffer (Promega R©) per well in a 12-well plate.
The oxidation reaction was catalysed by the addition of 50
l cell lysate to 50 l room temperature Bright-GloTM Lu-
ciferase Assay System (Promega R©) substrate and shielded
from the light for 5 mins. Luciferase activity was measured
using a luminometer with values normalised to mock trans-
fection controls.
In vitro sym/sub-based template switching assay
The sym/sub assay has been described previously (22).
Elongation complexes were assembled by incubating 5 M
WT or mutant poliovirus polymerase with 1 M sym/sub
RNA primer-template and 500 M ATP for 5 min (Mix
1). Unless otherwise specified, template-switching reactions
were initiated by addition of 60 M RNA acceptor tem-
plate and 500 M CTP, GTP and UTP (Mix 2) and then
quenched at various times by addition of 50 mM EDTA.
All reactions were performed at 30◦C in 50 mM HEPES,
pH 7.5, 10 mM 2-mercaptoethanol, 60 M ZnCl2, and 5
mM MgCl2. Products were analyzed by denaturing poly-
acrylamide gel electrophoresis, visualized using a Phospho-
rImager and the transfer products quantified using Image-
Quant software (GEHealthcare). The strand transfer prod-
uct was excised from the gel and sequenced following the
miRCat-33TM protocol (Integrated DNA Technologies).
CRE-REP recombination assay
TheCRE-REP assay for replicative recombinationwas con-
ducted as described previously (11) and similar conditions
were used for the 3′CRE-REP assay developed during this
study. Where specified, ribavirin was added to transfected
L929 monolayers at 600 M. Recombinant viruses were
quantified by plaque assay.
RESULTS
Polymerase fidelity and nucleotide turnover influences viral
recombination
Mutations to the viral polymerase can influence the fidelity
and nucleotide turnover rate of the enzyme. Previous stud-
ies have demonstrated that substitution of a glycine to ser-
ine at position 64 in the poliovirus polymerase (G64S) con-
fers resistance to ribavirin, a guanine-analog (23,24). We
have demonstrated that this mutation decreased recombi-
nant yield in an intertypic (poliovirus type 1 versus po-
liovirus type 3) CRE-REP assay by ∼20-fold whereas the
addition of ribavirin, which enhances the polymerase error
rate, increased recombinant yield in the same assay (11). To
determine whether independently identified polymerase fi-
delity variants similarly influenced recombination we inves-
tigated the consequences of a conserved lysine to arginine
substitution at residue 359 (K359R). This residue, located
within motif D of the polymerase adjacent to the active site,
is proposed to act as the general acid required for the second
protonation event during polymerase-catalyzed nucleotidyl
transfer (25). Polymerases bearing aK359R substitution re-
tain activity but turn over nucleotides at 5–10% the rate of
the unmodified protein and are both genetically-stable and
attenuating (26). We additionally studied the influence of a
polymerase with an extensively characterized (27) mutator
phenotype, bearing a histidine to arginine substitution at
residue 273 (H273R). This polymerase substitution has no
impact on virus replication (27) but increases the mutation
rate 3-fold and markedly attenuates the virus in vivo. Sim-
ilar low fidelity polymerases have recently been shown to
positively influence the yield of recombinant and defective
interfering (DI) virus in an alphavirus model (15).
We engineered the K359R or H273R substitutions
into poliovirus type 1 and type 3 sub-genomic replicons
and quantified luciferase production after transfection of
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Figure 1. Replication and recombination analysis of poliovirus bearing a K359R mutation in the viral polymerase. (A and B) Replication kinetics of
sub-genomic replicons of poliovirus type 1 (RLucWT – A) or poliovirus type 3 (Rep3-L – B). Unmodified (wild-type) replicons indicated with filled
circles, replicons bearing a K359R polymerase mutation with filled squares and wild-type replicons in the presence of 4mM guanidine hydrochloride,
an inhibitor of poliovirus RNA replication, with filled triangles. 250ng of RNA generated in vitro was transfected into HeLa cells. Samples were taken
at the times indicated and luciferase activity was measured and normalised using a mock transfected control. Error bars indicate standard deviation of
two independent samples. (C) Influence of G64S, H273R and K359R polymerase mutants on the yield of recombinants in an intertypic (grey bars) and
intratypic (black bars) CRE-REP recombination assay. Yield of recombinants is expressed as pfu/ml with error bars showing standard deviation from
at least three independent assays. Note that the intratypic and intertypic assays use different scale Y axes. The X axis indicates the identity of the viral
polymerase in both donor (sub-genomic replicon) and acceptor (SL3-derived genome) templates. Plaque assay quantities were independently confirmed
by TCID50 (data not shown).
HeLa cells with RNA synthesised in vitro. Both K359R-
containing replicons exhibited a marked delay in maxi-
mal luciferase synthesis and a lower overall yield, reaching
∼30% of the luciferase level generated by the unmodified
parental replicons (Figure 1A and B). We additionally en-
gineered the K359R or H273R substitutions into the po-
liovirus type 3-derived SL3 genome, generating SL3K359R
and SL3H273R respectively. We then conducted independent
CRE-REP recombination assays using the SL3K359R and
SL3H273R acceptor genomes with type 1 or type 3 sub-
genomic replicons bearing thematchingmutation,monitor-
ing the yield of inter- and intratypic recombinants produced
in 48 hours following transfection of murine L929 cells.
Using unmodified (WT) parental SL3 and sub-genomic
replicons yielded∼2200 pfu/ml (±571; all titres determined
in three or more independent assays and expressed ± SD)
and 114 pfu/ml (±29) in intratypic and intertypic CRE-
REP assays respectively, in broad agreement with previous
results (11). In parallel assays the previously characterized
G64S high fidelity polymerase variant produced 180 pfu/ml
(±14) and 7 pfu/ml (±5) in intra- and intertypic recombi-
nants respectively, the latter in agreementwith earlier results
(11). In the intertypic CRE-REP assay, genomes bearing the
H273R substitution yielded 346 pfu/ml (±83; Figure 1C),
an increase of ∼3-fold over the unmodified templates. A
comparable (∼3.3-fold) increase in recombinant yield was
also observed in the intratypic CRE-REP assay with tem-
plates bearing the same H273R variant polymerase. In con-
trast, the presence of the K359R mutation in both donor
and recipient genomes prevented the recovery of any viable
recombinants in either inter- or intratypic CRE-REP as-
says (Figure 1C). The results obtained with the low fidelity
H273R polymerase, together with the recombination phe-
notype of the high fidelity K359R and G64S (11) enzymes,
strongly support a role for polymerase fidelity as a key de-
terminant of recombination frequency.
Engineering the CRE into the 3′ non-coding region of the po-
liovirus genome
The frequency of recombination is presumably related to
the opportunity the polymerase has to switch templates. For
example, in previous studies we demonstrated that prevent-
ing replication complex coalescence (via nocodazole inhi-
bition of microtubule polymerisation) reduced the yield of
recombinants. Since the generation of viable recombinant
progeny in the CRE-REP assay is dependent upon a strand
transfer event occurring within the∼1kb separating the P1-
coding region of the sub-genomic replicon and the defective
CRE in the SL3 acceptor template (11) we reasoned that
increasing the separation of these selection markers should
also increase recombinant yield which would confer advan-
tages in analysis of polymerases with reduced nucleotide
turnover, such as K359R.
Since the majority of characterised naturally-occurring
recombinant enteroviruses exhibit recombination junctions
within the P2- or P3-coding regions of the genome we
wanted to modify the CRE-REP system to allow anal-
ysis of recombinants generated in vitro within a similar
region. We therefore altered the original poliovirus type
1 sub-genomic replicon (pRLucWT) to inactivate the na-
tive CRE in the 2C coding region by the introduction
of 8 synonymous substitutions (identical to those used
in the construction of the SL3 variants used here and
previously; (13)) to generate pRLucWTCRE. We con-
firmed that, as expected, RNA synthesized in vitro from
pRLucWTCRE and transfected into murine L929 cells
could not replicate (Figure 2A). The luciferase signal gen-
erated was similar in the presence or absence of 4 mM
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Figure 2. Replication and recombination of poliovirus with the CRE lo-
cated in the 3′ non-coding region. (A) Replication of sub-genomic po-
liovirus type 1 replicons expressing a luciferase reporter gene. Wild-type
(RLucWT) replicon in the absence (•) and presence () of 4mM guani-
dine hydrochloride, together with the replicon with the native CRE inacti-
vated (RLucWTCRE; ). The luciferase activity expressed by a replicon
with a synthetic CRE inserted into the 3′ NCR (RLucWTCRE 3′CRE)
in the absence () and presence of 4mM guanidine hydrochloride (). In
each case, 250ng of relevant RNA transcribed in vitro was transfected into
L929 cells in duplicate, samples were harvested at the time points indicated
and luciferase activity was measured and normalized using a mock trans-
fected control. (B) Representative crystal violet stained Hela cell monolay-
ers inoculated with supernatant obtained following transfection of RNA
transcribed in vitro from the relevant full-length cDNAs indicated. Infected
HeLa cells were covered with plaque assay overlay medium and stained 3
days post infection.
guanidine hydrochloride, a potent inhibitor of poliovirus
replication (28), indicating it was solely from translation of
the transfected RNA. We subsequently engineered a syn-
thetic variant of the CRE sequence into the 3′ NCR of
a pRLucWTCRE to generate pRLucWTCRE 3′CRE.
The synthetic CRE sequence used had previously been
shown to function when inserted into the 5′ NCR and con-
sisted of the terminal 18 nt. of the wild-type CRE sequence
engineered to form the terminal loop on a stem with sim-
ilar structural stability to the native element (Supplemen-
tary Figure S1). This sequence was known to be stable in
genomes bearing dual CRE sequences (21). RNA generated
in vitro from pRLucWTCRE 3′CREwas transfected into
murine L929 cells and luciferase synthesis monitored for
8 hours post-transfection. In parallel assays the luciferase
signal from pRLucWTCRE 3′CRE-derived RNA was
marginally greater than that from RNA generated from the
parental sub-genomic replicon, pRLucWT, confirming that
insertion of the CRE within the 3′ NCR was not incompat-
ible with genome replication (Figure 2A).
To ensure that the resulting modifications had not intro-
duced unexpected functional defects (e.g. disruption of en-
capsidation, a process critical for the identification of vi-
able recombinants in the CRE-REP assay) into the virus
genome we engineered the same mutations to the na-
tive CRE (creating pPV1FLCCRE) and 3′ NCR (cre-
ating pPV1FLCCRE 3′CRE) in a full length infectious
poliovirus type 1 cDNA (pPV1FLC). RNA generated in
vitro was independently transfected into murine L929 cell
monolayers and de novo generated supernatant virus was
quantified by subsequent plaque assay on HeLa cells.
pPV1FLCCRE yielded no measurable virus and subse-
quent blind serial passage did not lead to the emergence
of variants capable of replicating, a result in agreement
with comparable studies on poliovirus type 3 (13). In con-
trast, RNA from pPV1FLCCRE 3′CRE generated viral
plaques indistinguishable in appearance from the parental
unmodified cDNA (Figure 2B) with a yield of 6 × 108
pfu/ml, similar to the 4 × 108 pfu/ml yield from PV1FLC
under similar assay conditions. To further confirm that a
virus bearing the CRE in the 3′ NCR replicated with simi-
lar kinetics to the unmodified parental virus we conducted
competition experiments between the two viruses, broadly
recapitulating the conditions that would prevail in a mixed
infection recombination assay (Supplementary Figure S2).
The results demonstrated that the poliovirus CRE can be
relocated to the 3′ NCR without apparently compromising
virus replication, thereby making it a suitable template for
analysis of recombination throughout the region encoding
the virus non-structural proteins.
Extending the CRE-REP assay
The relocated CRE in the 3′ NCR is situated ∼2.9 kb
from it’s native position, extending the potential region for
recombination––the distance separating the VP1 capsid-
coding region (absent from the sub-genomic replicon)
and a functional CRE (absent from the SL3 parental
genome)––from ∼1 kb to almost 4 kb (Figure 3A). We
investigated intertypic recombination following transfec-
tion of murine L929 cells with RNA generated in vitro
from pRLucWTCRE 3′CRE and pT7FLC/SL3. In par-
allel, we conducted a control CRE-REP recombination
assay with RNA derived from parental pRLucWT and
pT7FLC/SL3 (Figure 3B). The latter generated 157 pfu/ml
(±20) whereas the assay with the extended recombination
region yielded an increase of ∼5.8-fold to an average of 920
pfu/ml (±317; Figure 3C). Preliminary analysis of recombi-
nation junctions in viruses recovered in the extended CRE-
REP assay (henceforth designated 3′CRE-REP) indicated
they were located throughout the region encoding the non-
structural proteins, with both imprecise and precise junc-
tions identified (Supplementary Figure S3).
We then used the 3′CRE-REP assay to investigate
whether the increased yield of recombinants was sufficient
to detect recombination in genomes bearing the K359R
mutation. Following transfection of RNA derived from
pRLucWTCRE 3′CRE and pT7FLC/SL3, with both
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Figure 3. An extended 3′CRE-REP recombination assay. (A) Schematic depiction of the 3′CRE-REP recombination assay. The acceptor genome (dark
shading) bearing a defective CRE indicated as a broken line in the 2C-coding region is shown above a representation of the donor genome, a luciferase-
encoding sub-genomic replicon (light shading) in which the native CRE has been inactivated and a synthetic CRE (indicated sCRE) inserted into the 3′
NCR. Following co-transfection of permissive cells (indicated by an arrow), a replication competent recombinant genome may be recovered of the generic
structure shown, consisting of the 5′ part of the genome derived from full-length, capsid-encoding, acceptor genome and the 3′ part from the luciferase-
encoding donor replicon. The crossover may occur within the region indicated. (B) Increased recombinant yields from the 3′CRE-REP assay. 250 ng of the
acceptor or each of the indicated donorRNAswere co-transfected into L929murine cells and supernatant harvested at 48 h post-transfection.Recombinant
virus present in similar dilutions of supernatant was compared by plaque assay in HeLa cells and stained 72 h post infection. (C) Comparison of intratypic
recombination yields from CRE-REP and 3′CRE-REP assays primed with RLucWT and FLC/SL3 donor and acceptor genomes. The presence of K359R
polymerase mutation in both donor and acceptor genomes prevented the generation of recombinants in the 3′CRE-REP assay. The data represents the
mean from three independent samples (± standard deviation). All plaque assay results were confirmed by TCID50 (data not shown).
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Figure 4. A biochemically-defined in vitro recombination assay. (A) Scheme for in vitro template-switching assay. A radiolabelled (end labelled, indicated
*) primer substrate pair known as sym/sub is the basis for the assembly of an elongation complex by the addition of ATP and purified polymerase protein.
Addition of remaining nucleotides allows complete extension of the sym/sub template to form a strong stop product. The latter is considered the donor
template to which acceptor template ribo-oligonucleotides are added. The complementary acceptor has six nucleotides (underlined) that have the potential
to pair with the 3′ end of the extended sym/sub donor product. An alternative acceptor template with no complementarity was also tested. The products
of the assay are analysed by polyacrylamide gel electrophoresis (PAGE). (B) Denaturing PAGE of in vitro reactions quenched at 5, 10, 20, 40 and 60 min
after addition of the UTP/CTP/GTP and acceptor template (indicated below) mix. Reactions conducted in the absence (-) or presence (+) of ATP only
indicated. The n + 1 product is the assembled elongation complex. The strong stop product is the fully extended sym/sub template. The high molecular
weight products result from a template switch to the indicated RNA acceptor.
cDNAs modified to include the K359R mutation in the
3Dpol coding region, no recombinants were recovered (Fig-
ure 3C). Therefore, although increasing the size of the re-
gion in which recombination could occur enhanced the
yield of recombinants, it was not sufficient to compensate
for the non-recombinogenic K359R mutation in the viral
polymerase.
A biochemically-defined recombination assay
To further investigate the strand-transfer reaction that must
occur during recombination we exploited a biochemically-
defined assay based upon the sym/sub system (22), a 10 nt.
heteropolymeric RNA primer-template symmetrical self-
complementary substrate (sym/sub) forming a 6 nt duplex
flanked with 4 nt. 5′ unpaired regions (Figure 4A). Pre-
vious studies using homopolymeric templates and primers
has suggested that purified poliovirus polymerase was suf-
ficient for the strand-transfer event (29). We therefore in-
vestigated modification of this well-characterised sym/sub
assay by inclusion of an acceptor template containing two
potential regions of limited complementarity with the pri-
mary extension product. Briefly, the two-stage reaction in-
volves assembling the radiolabeled sym/sub template with
purified polymerase and ATP (Mix 1) in a suitable buffer
to allow the formation of the elongation complex. Addi-
tion of the remaining nucleotides and an acceptor template
(Mix 2) enables extension and––potentially––strand trans-
fer, with the reaction products over a time course analysed
by polyacrylamide gel electrophoresis. The formation of an
n + 1 product indicates functional assembly of the elonga-
tion complex (Figure 4A andB) prior to the addition ofMix
2. This results in the rapid formation of a number of >n +
1 products including the fully extended sym/sub template
represented by the n + 4 product (‘Strong stop’, Figure 4A
and B). The generation of an n + 5 product is due to the
non-templated addition to the end of the primer template,
as previously described (29). The strand transfer product is
represented by a discrete band appearing after the addition
ofMix 2, the level of which increased as the reaction was in-
cubated for up to 60 min (Figure 4B). Quantification of the
strand transfer product at 30 min allowed the optimization
of experimental conditions, including polymerase and ac-
ceptor template concentrations (Arnold et al., manuscript
in preparation).
Under the optimized conditions a maximum yield of
∼5% of the strand transfer product was achieved after 30
min when catalyzed by the native virus RdRp at 5 M (Fig-
ures 4B and 5B). We reasoned that the acceptor template
needed to be present in molar excess over the sym/sub tem-
plate (1 M) to provide maximum opportunity for tem-
plate switching. As copy-choice recombination occurs dur-
ing negative-strand synthesis (30) we also reasoned that
a 60-fold excess of acceptor RNA over sym/sub template
would be biologically relevant. Indeed, previous research
has shown that negative strand synthesis is between 40–60-
fold in excess of positive strand RNA synthesis during the
early stages of RNA replication (31). The generation of a
strand transfer product was dependent upon both the pres-
ence (Figure 4B) and sequence of the acceptor template. We
initially investigated the suitability of an acceptor with a
similar base composition (the ‘Random’ acceptor, Figure
4B) and demonstrated it was incompatible with formation
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Figure 5. The influence of polymerase fidelity and acceptor template sequence. (A) Representative sym/sub template switching assays using the poliovirus
polymerase variants indicated. Denaturing PAGE was used to separate reaction products at 2, 4, 8, 10, 20 and 30 min after addition of the extension mix.
(B) Quantification of the transfer product generated by WT (•), H273R () and G64S () polymerases as a percentage of total RNA products per sample
over time. Results are the average from three independent experiments and error bars indicate standard deviation. (C) Denaturing PAGE gel of in vitro
sym/sub reactions quenched at 30 minutes after the addition of the extension mix containing complementary (WT) or acceptor RNAs truncated at the 3′
end by one, two, or three nucleotides (D31, D32 and D33 respectively) as shown.
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of the transfer product.We extended this analysis to investi-
gate the specific involvement of 3′ sequences in the acceptor
by using each of three RNA molecules that were truncated
by one, two or three nucleotides at the 3′ end, but were oth-
erwise identical to the complementary RNA acceptor (Fig-
ure 5C). None could be incorporated into a transfer prod-
uct.
sym/sub analysis of fidelity polymerase variants
The development and optimization of a biochemically de-
fined sym/sub recombination assay confirmed that the viral
polymerase was the only protein required for formation of
the strand transfer product. This assay therefore provides
an experimental environment to investigate the direct influ-
ence of polymerase on strand transfer. Using the optimized
conditions already established (Arnold et al., manuscript in
preparation) we investigated the formation of the sym/sub
strand transfer product by G64S, H273R and K359R poly-
merase fidelity mutants by quantifying the production of
the strand transfer product 30 min after addition of accep-
tor template and nucleotides to the reaction. The high fi-
delity G64S polymerase variant generated 1.8-fold less of
the strand transfer product compared towild type at 30min.
In contrast, the H273R low fidelity variant increased tem-
plate transfer product 3-fold. Strikingly, the generation of
the strand transfer product by the K359R polymerase was
so low that accurate quantification over a 30 minute time
course was not possible (Figure 5A and B).
Sequence analysis of the strand transfer product
The observations in both CRE-REP and sym/sub assays
indicated that polymerase fidelity was a key determinant of
strand transfer efficiency. The demonstration that the ma-
jority of the strand transfer products were of a minimum
uniform size suggested there may be some sequence speci-
ficity to the in vitro recombination event, presumably in-
volving one or other of the two limited regions of comple-
mentarity with the primary extension product (Figure 4A).
In order to gain insight into the strand switching event we
isolated the transfer product and subsequently cloned and
sequenced the RNA species. Over 100 sequences were ob-
tained, analysis of which resulted in two striking observa-
tions (Table 1). Firstly, the template switch occurred at the
3′ end of the acceptor template not at the internal region
of complementarity. Secondly, a significant number of mis-
incorporations or non-templated nucleotide additions oc-
curred at or near the junction of the sym/sub donor and
acceptor templates. Many of these involve the addition of C
nucleotides, thereby increasing the potential for C–G base
pairing with the 3′ end of the acceptor template. Only one of
the sequences obtained showed no evidence of misincorpo-
ration or non-templated base additions. These observations
support the role of polymerase fidelity in strand transfer
and, together with the failure to observe a strand transfer
product with random or truncated acceptor templates (Fig-
ures 4B and 5C), indicate that minimal regions of sequence
complementarity are required for recombination in vitro.
DISCUSSION
Recombination in mammalian positive sense RNA viruses,
such as poliovirus, is a relatively poorly characterizedmech-
anism responsible for the generation of extensive genetic
variation in the progeny of co-infections. In a recent study
we demonstrated that replicative recombination (i.e. in
which both parental viruses are replication-competent, to
distinguish it from a distinct non-replicative process that
has also been described (16,17)) is a biphasic process that
involves distinct strand-transfer and resolution events (11).
Both phases are necessary for the generation of genome-
length recombinants that circulate in the population (7,10).
The CRE-REP assay developed in our previous study en-
abled both viral and cellular determinants of these phases
to be investigated. However, being cell-based, it did not al-
low the influence of the viral polymerase to be defined and
studied in isolation. Furthermore, recombination was only
quantifiable within a limited region of the genome. We ad-
dress both these restrictions here. We describe a modified
CRE-REP assay inwhich recombination throughout the re-
gion encoding the viral non-structural proteins can be anal-
ysed. In addition, we show that recombination can be reca-
pitulated in a defined biochemical system in which the only
protein present is the viral polymerase. We use these two
strategies to investigate the role of RNA dependent RNA
polymerase fidelity and nucleotide turnover rate in the ge-
netic recombination of poliovirus.
We had previously demonstrated that aG64S high fidelity
polymerase variant significantly reduced (∼20-fold) the re-
combination rate observed in the CRE-REP assay. We ex-
tended this study by investigating the influence of K359R
Table 1. Sequence analysis of strand transfer products
# Misincorporation Untemplated Sequence 5′-GCAUGGGCCC . . . -3′
24 +C AUGC C AUGC AUGC UUGC N0-3
20 +CC AUGC CC AUGC AUGC UUGC N0-3
2 G→C +C AUCC C AUGC AUGC UUGC N0-3
38 G→C AUCC AUGC AUGC UUGC N0-3
14 (U/G)→C ACC AUGC AUGC UUGC N0-3
4 +A(C/U)C AUGC A(C/U)C AUGC AUGC UUGC
1 AUGC AUGC UUGC
1 G AUC AUGC UUGC
The first column indicates the total number of each sequence obtained, all of which were preceded with the core sym/sub sequence shown in the header
line. Underlined nucleotides indicate misincorporations or untemplated additions (summarised in the indicated columns on the basis of the differences
between the observed and expected [the latter highlighted in bold] sequences) at or near the junction of the sym/sub donor and acceptor sequences. N
indicates the untemplated addition of any nucleotide, nucleotides in brackets indicate alternates, G indicates a single nucleotide deletion.
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and H273R polymerase mutants, which are reported to ex-
hibit higher and lower fidelity than the native enzyme re-
spectively (26,27). In all instances, the relevant polymerase
mutation was present in both the donor (sub-genomic repli-
con) and acceptor (SL3-derived) templates. In contrast to
theG64S results, the presence of theH273Rmutation led to
at least a 3-fold increase in recombinant yield (Figure 1C),
suggesting that low fidelity increases the rate of template
switching by the viral polymerase, a result in agreement
with a recent study in alphaviruses (15). Both the G64S
and H273R variations have little impact upon the replica-
tion of poliovirus or sub-genomic replicons in cell based as-
says (27,32) indicating that fidelity alone may account for
the changes in recombination rates measured in the CRE-
REP assay. With the K359R mutation we were unable to
detect any intra- or intertypic recombinants using the CRE-
REP assay under conditions previously shown to yield vi-
able progeny from G64S-containing templates (Figure 1C).
Since the K359R polymerase has a lower fidelity than the
G64S enzyme (26), fidelity alone cannot explain the dif-
ferent phenotypes of these enzymes in this assay. However,
the K359R mutation also catalyses nucleotidyl transfer at
10% the rate of the unmodified enzyme (25,26), an observa-
tion we verified in luciferase assays using poliovirus type 1
or type 3 sub-genomic replicons (Figure 1A and B), which
could also influence the recombination process. If there was
a directly proportional relationship between replication rate
and recombinant yield, we would have expected to detect
recombinants in the intratypic CRE-REP assay (where the
native enzyme generated ∼103 pfu/ml) even if they were
undetectable in the intertypic assay which is ∼20-fold less
sensitive. However, when investigated (Figure 1C), the ab-
sence of recombinants in the intratypic CRE-REP assay by
K359R-containing genomes, indicates that the yield was at
least 3log10 lower, implying that replication rate and poly-
merase fidelity may exert a cumulative influence on recom-
bination. Previous studies have already indicated that there
is a direct relationship between elongation rate and poly-
merase fidelity (26,33). Due to the pleiotropic effect of mu-
tations such as K359R on the activities of the polymerase
it is difficult to determine the relative importance of these
two polymerase phenotypes on recombination. In an at-
tempt to achieve this we have investigated the consequences
of adding the mutagen ribavirin on recombinant recovery
in the CRE-REP assay primed with donor and acceptor
RNAs bearing the high-fidelity G64S mutation (which ex-
hibits similar processivity to the native enzyme (26)). Rib-
avirin at 600M enhanced the yield of recombinants from
either the intertypic or intratypic CRE-REP assay 2- to 3-
fold (Supplementary Figure S4) providing additional con-
firmation that fidelity per se is a key determinant of the
template switching events in recombination. Ribavirin at a
similar concentration could not rescue recovery of recombi-
nants from CRE-REP assays primed with templates bear-
ing the K359R polymerase mutation (data not shown).
We reasoned that increasing the region within which re-
combination could occur in the CRE-REP assay might
compensate for the reduced replication of the K359R poly-
merase mutant. We tested this by further separating the
lesions that rendered the donor and recipient templates
incapable of alone generating viable progeny, which we
achieved by introducing a synthetic variant of the CRE
to the 3′ NCR. In doing this, we demonstrated that the
poliovirus CRE is functional in the 3′ NCR, 2.9 kb away
from the native location and 6.8 kb distant from the 5′
NCR location previously reported (21). The robust replica-
tion ofRLucCRE 3′CRE (Figure 2A andB) convincingly
demonstrates the positional independence of the poliovirus
CRE, as has also been shown for foot and mouth disease
virus (34). Using a donor template (Figure 3A and C) with
the CRE in the 3′ NCR increased recombinant yield by
∼5.8-fold in the modified 3′-CRE-REP assay over the orig-
inal assay. The increased yield of recombinants was approx-
imately proportional to the increase in separation of the ge-
netic lesions used for the selection (5.8-fold versus 4-fold re-
spectively). We interpret this as indicating there were no sig-
nificant recombination ‘hotspots’ within the non-structural
coding region that were absent from the ∼1 kb recombina-
tion window in the original CRE-REP assay. This conclu-
sion is supported by preliminary analysis of a limited panel
of recombinants from the 3′CRE-REP assay which indi-
cated they were distributed throughout the region encod-
ing the viral non-structural proteins (Supplementary Fig-
ure S3), with limited evidence of clustering at the 2C/3A
boundary and the region encoding the C-terminus of the
polymerase. We have previously suggested that the cluster-
ing of imprecise recombinants could be explained by func-
tional constraints on the initial hybrid virus genome (11).
The extended opportunity for recombination offered by the
3′CRE-REP assay will allow the influence of RNA struc-
ture, sequence identity and these functional constraints to
be more fully examined in future studies.
Notwithstanding the increased yield of recombinants ob-
tained from the 3′CRE-REP assay with the unmodified
polymerase, inclusion of the K359R mutation completely
inhibited the formation of detectable recombinant progeny
(Figure 1C). This provides further support for this muta-
tion having a non-recombinogenic phenotype, but does not
help elucidate the role of reduced nucleotide incorporation
and/or increased fidelity in achieving this behaviour.
A notable feature of the replication of the K359R poly-
merase is the apparent ‘stall’ in replication from around
2 to 6 h post-transfection. This was reported in a previ-
ous study (26) and also observed in sub-genomic replicons
bearing this substitution (Figure 1A and B). During this
period replication is occurring, but at a markedly reduced
rate when compared to genomes bearing the native poly-
merase. After 6–8 h, replication gradually picks up, result-
ing in an overall yield ∼1log10 lower than the wild-type
virus (26). The early events in genome replication include
the formation and subsequent coalescence of membrane-
anchored replication complexes (18,35). If one or more of
these events is delayed, either directly by the action or in-
teractions of the K359R polymerase, or indirectly because
of reduced genome replication, then the yield of recom-
binants may be reduced. Nocodazole and cold treatment,
which prevents microtubule re-polymerization, inhibits co-
alescence of RC and yield of recombinants (11,18). More
compellingly, reversible stalling of virus replication using
guanidine hydrochloride, also resulted in inhibition of the
mobility of RCs (36). To try and discriminate between a di-
rect influence of the K359R viral polymerase on the strand
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transfer event per se, and a defect in one or more of the cell-
related events required for recombination, we investigated
the process in a system inwhich the polymerase was the only
protein present.
We exploited the well-characterised sym/sub assay that
has previously been used to analyse the phenotype of the
poliovirus polymerase in a biochemically-defined system.
Briefly, an elongation complex is assembled on a 10 nt self-
complementary template in the presence of ATP alone and
the stalled extension relieved by addition of the remain-
ing nucleotides. By inclusion of an acceptor template with
limited complementarity to the primary extension product
(Figure 4A and B) we were able to demonstrate the forma-
tion of a specific strand-transfer product which exhibited
the expected reduced mobility, confirming that the poly-
merase alone is necessary for template switching during re-
combination. We used this assay to explore the influence of
polymerase variants or the sequence of the acceptor tem-
plate on the production of the strand-transfer product.
Our results strongly suggest that interactions of the donor
and acceptor templates are important during recombina-
tion in vitro. An acceptor oligonucleotide with 6 nt. of com-
plementarity (to the ‘strong stop’ extension product; un-
derlined in Figure 4A) at its 3′ end was incorporated into
the strand-transfer product, the length of which (Figure 4B)
and subsequent sequencing (Table 1) indicated it is the posi-
tion at which the polymerase switches template from donor
to acceptor. The sequence specificity of this interaction was
emphasised by the inability to generate a detectable strand-
transfer product in the presence of an acceptor template
with no complementarity (Figure 4B) or with acceptor tem-
plates truncated by 1–3 nucleotides at the 3′ end (Figure
5C). This analysis clearly demonstrates that the presence
of two G nucleotides at the 3′ end of the acceptor––and
complementarity between donor and acceptor template 3′
ends––was critical for generation of the transfer product.
Sequence analysis of the strand transfer product (Ta-
ble 1) provides further insight to the importance of the
two G nucleotides at the 3′ end of the acceptor. The ma-
jority of the sequences exhibited additional cytidine nu-
cleotides at or near the recombination junction between
the sym/sub donor and acceptor templates. Over 50% of
the sequences included misincorporations, primarily of G
to C, which would increase the sequence complementar-
ity with the G dinucleotide at the 3′ end of the accep-
tor. In addition, an equivalent proportion (∼48%) of the
sequences showed evidence of one or two non-templated
C nucleotides at the junction. These presumably account
for the reduced mobility apparent in some ‘strong stop’
products (Figures 4B and 5A) and would again increase
the sequence complementarity between donor and ac-
ceptor molecules. Of the 104 transfer product sequences
obtained, only one contained no sequence substitutions,
additions or deletions from the expected product (5′-
GCAUGGGCCCAUGCAUGCUUGC-3′). This level of
variation has not been observed in the sequence of pre-
sumed recombination junctions in previous studies (1,37–
41) or in our recent analysis using the CRE-REP assay ((11)
and Bentley et al., manuscript in preparation), all of which
involved analysis of replication-competent genomes. How-
ever, these analysed junctions were predominantly located
within the polyprotein-coding region which, if disrupted,
would be incompatible with virus viability. Over 60% of the
strand transfer products sequenced (Table 1) contained ad-
ditional nucleotides which would have resulted in the pre-
mature truncation of the open reading frame (ORF), and
those in which the ORF remained intact contained addi-
tional amino acids, potentially poorly tolerated in the viral
polyprotein. This strongly suggests that stringent functional
selection of a diverse population of recombinant molecules
may generate a much more limited subset of sequences
which are observed in replication-competent viral popula-
tions.
Although the non-templated addition of nucleotides to
the 3′ end of the donor was important in enhancing com-
plementarity with the acceptor it does not alone account
for the ability of the polymerase to generate a strand trans-
fer product. The K359R polymerase generates reduced-
mobility ‘strong stop’ products, indicative of this untem-
plated addition, but was unable to generate recombinant
products in either the sym/sub or CRE-REP assays (Fig-
ures 1C and 5A). Additional polymerase fidelity mutants
tested in the sym/sub assay also recapitulated the pheno-
types previously characterized in the cell-based CRE-REP
assay (Figures 1C, 4A and 5A). The low fidelity H273R
polymerase yielded ∼3-fold more transfer product in the
sym/sub assay and at least 3-fold more recombinants in the
CRE-REP assay when compared with the unmodified poly-
merase. Similarly, in both the biochemical and cell-based
assay the high fidelity G64S mutant polymerase exhibited
a reduced yield, by ∼2-fold and ∼20-fold respectively (11).
These results emphasise the relevance of the sym/sub re-
combination assay and allow the detailed dissection of
the contributions of polymerase, the donor and acceptor
molecules in the strand transfer event. This should pro-
vide important insights into the molecular mechanism of
recombination in enteroviruses and, by extrapolation, other
single-stranded RNA viruses. It may additionally help un-
derstand the processes involved in other polymerase/RNA
interactions in which discontinuous RNA sequences are
juxtaposed in the resulting product, for example during
the generation of internally-deleted defective interfering
genomes (42) or the involvement of the body and leader
transcriptional regulatory sequences implicated in discon-
tinuous subgenomic transcription in coronaviruses (43).
It is clear that the phenotype of the K359R mutant poly-
merase is of wider significance. This mutation lies within
motif D, a conserved element present in all RNA dependent
RNA polymerases, where the lysine acts as a general acid
for nucleotidyl transfer (25,44,45). Not only does K359R
attenuate poliovirus neurovirulence (26) but it is now shown
that it also inhibits the frequency of template switching. Re-
combination between live attenuated Sabin vaccines and co-
circulating species C enteroviruses is regularly observed and
associated with paralytic disease (7,46,47). Once poliovirus
eradication is achieved a K359R-containing variant could
be considered as a suitable vaccine seed until global po-
liovirus vaccination programs are terminated.
Using the CRE-REP assay we have defined the recombi-
nation of enteroviruses as a biphasic process, with distinct
recombination and resolution events. Of these, the first gen-
erates ‘imprecise’ junctions, effectively consisting of limited
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duplications within the genome. Sequence analysis of sev-
eral hundred of these has failed to detect any sequence speci-
ficity to the process ((11) and unpublished). In contrast, the
junctions resulting from the resolution event always contain
‘ambiguities’ where it is unclear whether the sequence at the
junction is derived from the donor or recipient template.
This implies that there may be a requirement for comple-
mentarity for resolution. Formally, recombination is a trans
event involving the joining of separate molecules whereas
resolution could occur either in cis or in trans. It is there-
fore interesting to note the sequence complementarity re-
quired for the generation of the strand-transfer product in
the sym/sub assay which, by definition, must occur in trans.
Further studies will determine whether the biochemically-
defined sym/sub recombination assay is actually recapitu-
lating the primary recombination or secondary resolution
events described.
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